Table 5.
Manifestations not included in CoMiSS score and their improvement in response to CMFD.
| All patients (n = 100) | Cow milk allergy | Test of significance p value | ||
|---|---|---|---|---|
| Negative (n = 16) | Confirmed (n = 84) | |||
| Persistent significant mucoid stool | 80/100 (80.00%) | 8/16 (50.00%) | 72/84 (85.71%) | 0.001* |
| Patients with improved mucoid stool (out of all patients with positive mucoid before (n = 80)) | 72/80 (90.00%) | 5/8 (62.50%) | 67/72 (93.06%) | 0.006* |
| Bloody stool | 41/100 (41.00%) | 4/16 4 (25.00%) | 37/84 (44.05%) | 0.155 NS |
| Patients with improved bloody stool (out of all patients with bloody stool before (n = 41)) | 37/41 (90.24%) | 2/4 (50.00%) | 35/37 (94.59%) | 0.004* |
| Hematemesis | 11/100 (11.00%) | 2/16 (12.50%) | 9/84 (10.71%) | 0.834 NS |
| Patients with improved hematemesis (out of all patients with hematemesis before (n = 11)) | 10/11 (90.90%) | 2/2 (100.00%) | 8/9 (88.89%) | 0.624 NS |
| Marked abdominal distention not resolving on regular treatment | 77/100 (77.00%) | 13/16 (81.25%) | 64/84 (76.19%) | 0.659 NS |
| Patients with improved abdominal distention (out of all patients with abdominal distention before (n = 77)) | 66/77 85.71% | 8/13 (61.54%) | 58/64 (90.63%) | 0.006* |
| Faltering growth | 52/100 (52.00%) | 10/16 (62.50%) | 42/84 (50.00%) | 0.421 NS |
| Weight gain after 1 month of elimination (g), median [IQR] | 470 [250] | 225 [300] | 500 [225] | 0.001* |
* statistically significant, NS non significant.